Pre-tax profits at PJT Partners rose by more than a third in the second quarter, as the advisory firm set up by ex-Morgan Stanley banker Paul Taubman continued to land roles on landmark mergers and acquisitions.
New York-based PJT, which was named among the advisers on another big deal in the pharmaceuticals sector on Monday, reported pre-tax profits of $13.5m for the period. Revenues beat analyst expectations by rising 28% to $166m.
